Benjamin Speich

13PUBLICATIONS
49CO-AUTHORS
Speciation and extinctionApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical molecular engineering of nucleic acids and proteinsRegenerative medicine (incl. stem cells)Ethical use of new technology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Apr 20, 2026
Linezolid in addition to standard antibiotic treatment for <i>Staphylococcus aureus</i> bacteraemia: study protocol for a randomised, placebo-controlled trial.

|Jan 24, 2025
Low agreement and frequent invalid controls in two SARS-CoV-2 T-cell assays in people with compromised immune function.

Annette Audigé, Alain Amstutz, Macé M Schuurmans

|Jun 07, 2024
Antibody and T-Cell Response to Bivalent Booster SARS-CoV-2 Vaccines in People With Compromised Immune Function: COVERALL-3 Study.

Alain Amstutz, Frédérique Chammartin, Annette Audigé

|Nov 29, 2023
Antibody Response After the Third SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients and People Living With HIV (COVERALL-2).

Alexandra Griessbach, Frédérique Chammartin, Irene A Abela

|Apr 10, 2023
Antibody Response After Third Vaccination With mRNA-1273 or BNT162b2: Extension of a Randomized Controlled SARS-CoV-2 Noninferiority Vaccine Trial in Patients With Different Levels of Immunosuppression (COVERALL-2).

Alexandra Griessbach, Frédérique Chammartin, Irene A Abela

|Jul 27, 2022
A longitudinal assessment of trial protocols approved by research ethics committees: The Adherance to SPIrit REcommendations in the UK (ASPIRE-UK) study.

Benjamin Speich, Ayodele Odutayo, Nicholas Peckham

Pageof 3

Frequent Collaborators

6 joint publications

Matthias Briel

3 joint publications

Katharina Kusejko

2 joint publications

Erik von Elm

2 joint publications

Dominik Mertz